Cargando…

Effects of a Novel Bradykinin B1 Receptor Antagonist and Angiotensin II Receptor Blockade on Experimental Myocardial Infarction in Rats

BACKGROUND: The aim of the present study was to evaluate the cardiovascular effects of the novel bradykinin B1 receptor antagonist BI-113823 following myocardial infarction (MI) and to determine whether B1 receptor blockade alters the cardiovascular effects of an angiotensin II type 1 (AT1) receptor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Dongmei, Lin, Xinchun, Bernloehr, Christian, Hildebrandt, Tobias, Doods, Henri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517424/ https://www.ncbi.nlm.nih.gov/pubmed/23236443 http://dx.doi.org/10.1371/journal.pone.0051151

Ejemplares similares

THU596 Heteromerization Of The Angiotensin II Type 1 Receptor And The Bradykinin Type 2 Receptor
por: Johnstone, Elizabeth K M, et al.
Publicado: (2023)

Bradykinin B(2) receptor blockade and intradialytic hypotension
por: Gamboa, Jorge L., et al.
Publicado: (2023)

Sabiporide Reduces Ischemia-Induced Arrhythmias and Myocardial Infarction and Attenuates ERK Phosphorylation and iNOS Induction in Rats
por: Doods, Henri, et al.
Publicado: (2013)

Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor
por: Johnstone, Elizabeth K. M., et al.
Publicado: (2022)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers()
por: Douillard, Marie, et al.
Publicado: (2023)

164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors
por: Rasaeifar, Bahareh, et al.
Publicado: (2020)

Reversal of pulmonary arterial hypertension and neointimal formation by kinin B1 receptor blockade
por: Rampa, Dileep Reddy, et al.
Publicado: (2021)

The bradykinin BK2 receptor mediates angiotensin II receptor type 2 stimulated rat duodenal mucosal alkaline secretion
por: Ewert, Sara, et al.
Publicado: (2003)

Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice
por: Rampa, Dileep Reddy, et al.
Publicado: (2022)

Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis
por: Meng, Xin, et al.
Publicado: (2021)

Angiotensin II Receptor Blocker Attenuates Intrarenal Renin-Angiotensin-System and Podocyte Injury in Rats with Myocardial Infarction
por: Wen, Zhu-zhi, et al.
Publicado: (2013)

Administration of angiotensin II and a bradykinin B2 receptor blocker in midpregnancy impairs gestational outcome in guinea pigs
por: Valdés, Gloria, et al.
Publicado: (2014)

Spectrofluorimetric method for determination of some angiotensin II receptor antagonists
por: El-Shaboury, Salwa R., et al.
Publicado: (2012)

Angiotensin II receptor antagonists a potential therapy for SARS
Publicado: (2013)

Pharmacologic Targets and Prototype Therapeutics in the Kallikrein-Kinin System: Bradykinin Receptor Agonists or Antagonists
por: Sharma, J. N., et al.
Publicado: (2006)

Bradykinin receptor expression and bradykinin-mediated sensitization of human sensory neurons
por: Yi, Jiwon, et al.
Publicado: (2023)

Combination of β Adrenergic Receptor Block and Renin–Angiotensin System Inhibition Diminished the Angiotensin II-Induced Vasoconstriction and Increased Bradykinin-Induced Vasodilation in Hypertension
por: Lezama-Martínez, Diego, et al.
Publicado: (2017)

Angiotensin-receptor blockade in acute stroke
por: Rajendran, Srijithesh P.
Publicado: (2011)

Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade
por: Tsukuda, Kana, et al.
Publicado: (2016)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

Effect of angiotensin II type 1 receptor antagonist valsartan on cardiac remodeling and left ventricular function in patients with acute ST-elevation myocardial infarction.
por: Eduard, Ovricenco, et al.
Publicado: (2008)

Cardioprotective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors
por: Méndez-Valdés, Gabriel, et al.
Publicado: (2022)

In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B(2) Receptor Antagonist
por: Lesage, Anne, et al.
Publicado: (2020)

Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
por: Haaland, Kirsti
Publicado: (2010)

Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure
por: Wegleiter, K., et al.
Publicado: (2018)

Influence of Angiotensin II Subtype 2 Receptor (AT(2)R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT(1)R) Blockade
por: Jones, Emma S., et al.
Publicado: (2012)

Angiotensin Receptor Neprilysin Inhibitor Attenuates Myocardial Remodeling and Improves Infarct Perfusion in Experimental Heart Failure
por: Pfau, Daniel, et al.
Publicado: (2019)

Association between Angiotensin II Type 1 Receptor Polymorphism and Sudden Cardiac Death in Myocardial Infarction
por: Kruzliak, Peter, et al.
Publicado: (2013)

Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction
por: Lee, Jang Hoon, et al.
Publicado: (2016)

Functional Characterisation of the CGRP Antagonist BIBN4096BS, in SK-N-MC Cells
por: Schindler, Marcus, et al.
Publicado: (2001)

Bradykinin B1 receptor antagonist protects against cold stress–induced erectile dysfunction in rats
por: Ruze, Abudureyimujiang, et al.
Publicado: (2023)

Prenatal hypocalvaria after prolonged intrauterine exposure to angiotensin II receptor antagonists
por: Lallemant, Marine, et al.
Publicado: (2018)

Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis
por: Escobar, Johao, et al.
Publicado: (2023)

Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference
por: Safari, Tahereh, et al.
Publicado: (2013)

Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients
por: Lin, Yu-Li, et al.
Publicado: (2019)

Disruption of cardiovascular circadian rhythms in mice post myocardial infarction: relationship with central angiotensin II receptor expression
por: Mousa, Tarek M., et al.
Publicado: (2014)

The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
por: Kotak, Sohny, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4uo85quoj8l91vhbep02jqbqva